Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled
评估综合多模式门诊康复计划以改善 SARS-CoV-2 感染急性后遗症患者的功能 (PASC):一项随机对照研究
基本信息
- 批准号:10583969
- 负责人:
- 金额:$ 69.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-12 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAddressAdvisory CommitteesAerobicAnxietyBreathingCOVID-19COVID-19 severityCOVID-19 survivorsCOVID-19 vaccineCaringClinicClinicalCognitionCognitive remediationConsensusContractsDataDiagnosisDiffusionDiseaseEducational MaterialsEffectivenessEffectiveness of InterventionsEnrollmentFatigueGrowthGuidelinesHealthHealth systemIncidenceIndividualInfectionInpatientsInterventionLongitudinal SurveysMeasuresMental DepressionMuscleNeuropsychologyOutcomeOutpatientsPainPatient CarePatient EducationPatientsPersonsPoliciesPolicy DevelopmentsPopulationPost-Acute Sequelae of SARS-CoV-2 InfectionProgram DevelopmentPsyche structureRandomizedRandomized, Controlled TrialsRecommendationRecoveryRehabilitation therapyReportingResearchResistanceRespiratory DiaphragmSARS-CoV-2 infectionSARS-CoV-2 negativeSARS-CoV-2 positiveSamplingSelf ManagementSeveritiesSocial FunctioningStandardizationStressStretchingSurveysSurvivorsSymptomsSyndromeSystemTestingTimeTitrationsVaccinatedVaccinesVariantVirusWorkacute infectionacute symptomcognitive functionconditioningcoronavirus diseasecostcost comparisoncost effectivecost effectivenesscost estimateeffectiveness evaluationeffectiveness testingevidence baseexperienceflexibilityfunctional improvementfunctional restorationgroup interventionimprovedimproved outcomeintervention costintervention effectlong-term sequelaemultidisciplinarymultimodalitypatient orientedpersistent symptompilot trialpost-COVID-19preventprimary outcomeprogramspsychologicreduce symptomsrehabilitative caresecondary outcomesevere COVID-19symptom managementtreatment as usualtrial designwalking speed
项目摘要
About 10-20% of persons who contract SARS CoV-2 will experience persistent post-acute sequelae of SARS-
CoV-2 infection (referred here as PASC). Given that persistent symptoms are heterogeneous with multisystem
involvement, recent consensus recommendations suggest that a holistic rehabilitation program may be
required to manage PASC and restore function. While treatments offered at emerging outpatient COVID
recovery clinics are being informed by previous similar diseases, the need is great for a better understanding of
the unique needs of this growing population and for tested, efficacious rehabilitation programs to address
them. We provide both here. Specifically, our aims are: (1) To quantify the incidence and severity of PASC
across different variants and their effects on health and functioning; (2) To develop and evaluate the
effectiveness of a patient-centered, interdisciplinary, multimodal comprehensive rehabilitation program among
patients with PASC; and (3)To estimate the costs associated with the proposed PASC rehabilitation
intervention and to examine the relationship between intervention’s costs and effectiveness and their
implication for rehabilitation program initiatives. Data from a large and diverse ongoing longitudinal survey of
persons who tested for COVID-19 at the study health system will serve as the sampling frame from which to
identify and enroll PASC patients in the study. The targeted six-week program will be comprised of a core set
of therapies, including individually titrated stretching and flexibility, strengthening of accessory breathing
muscles and diaphragm, resistance and aerobic conditioning, and vestibular rehabilitation, supplemented by
neuropsychological and cognitive remediation tailored to patients’ needs. Using a randomized controlled trial
(RCT) design, the effectiveness of the intervention will be compared to that of usual care augmented by a one-
time in-person assessment and patient education materials. In addition to walking speed, a widely used global
measure of aerobic capacity and endurance, and patient-reported health and functioning (primary outcomes),
we will assess the intervention effectiveness on: (i) cognitive functioning, (ii) pain, (iii) fatigue, (iv) tension,
stress, anxiety, and depression, and (v) self-management of PASC symptoms (secondary outcomes).
Outcomes will be measured at fixed points in time at 8 weeks (shortly after therapy completion) and at 90 day’s
post- study entry to examine sustainability of effects. Our overarching hypothesis is that that higher
intervention costs in the intervention group will be more than offset by greater improvements in outcomes
implying that, overall, persons in the intervention group will receive more cost-effective care than those in usual
care group. Given the dearth of rigorous scientific evidence regarding effective assessment and treatment of
PASC and the unresolved questions concerning access to and value of post-COVID rehabilitation care, the
results of this study will have significant implications for both policy and program development.
约10-20%感染SARS CoV-2的人会出现持续的SARS急性期后后遗症-
CoV-2感染(简称PASC)。考虑到持续性症状是异质性的,
参与,最近的共识建议表明,一个整体的康复计划可能是
管理PASC和恢复功能所需的。虽然新出现的门诊COVID提供的治疗
康复诊所正在了解以前的类似疾病,需要更好地了解
这一不断增长的人口的独特需求,并为测试,有效的康复计划,以解决
他们我们在这里提供两者。具体而言,我们的目标是:(1)量化PASC的发病率和严重程度
(2)开发和评估不同的变体及其对健康和功能的影响;
以患者为中心的跨学科多模式综合康复计划的有效性
PASC患者;(3)估计与建议的PASC康复相关的费用
干预,并审查干预的成本和效果之间的关系,
对康复计划倡议影响。数据来自一项正在进行的大规模和多样化的纵向调查,
在研究卫生系统进行COVID-19检测的人员将作为抽样框架,
在研究中识别并招募PASC患者。有针对性的六周计划将包括一个核心集
治疗,包括个别滴定拉伸和灵活性,加强辅助呼吸
肌肉和横膈膜,阻力和有氧调节,前庭康复,辅以
神经心理学和认知补救适合患者的需求。使用随机对照试验
(RCT)设计,干预的有效性将被比较,以增加一个-
时间在人的评估和病人的教育材料。除了步行速度,一个广泛使用的全球性的
有氧能力和耐力的测量,以及患者报告的健康和功能(主要结局),
我们将评估干预对以下方面的有效性:(i)认知功能,(ii)疼痛,(iii)疲劳,(iv)紧张,
压力、焦虑和抑郁,以及(v)PASC症状的自我管理(次要结局)。
将在8周(治疗完成后不久)和90天的固定时间点测量结局
研究后进入,以检查影响的可持续性。我们的首要假设是,
干预组的干预成本将被结果的更大改善所抵消
这意味着,总的来说,干预组的人将获得比普通组更具有成本效益的护理,
关怀小组鉴于缺乏关于有效评估和治疗的严格科学证据,
PASC和尚未解决的问题,有关获得和价值的COVID后康复护理,
这项研究的结果将对政策和方案的制定产生重大影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY R DILLINGHAM其他文献
TIMOTHY R DILLINGHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY R DILLINGHAM', 18)}}的其他基金
Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth
为下肢缺失的儿童和青少年提供可调节假肢接受腔以适应生长
- 批准号:
10658207 - 财政年份:2022
- 资助金额:
$ 69.63万 - 项目类别:
Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth
为下肢缺失的儿童和青少年提供可调节假肢接受腔以适应生长
- 批准号:
10382682 - 财政年份:2021
- 资助金额:
$ 69.63万 - 项目类别:
Evaluating the Effects of CMS' Prospective Episode-Based "Bundling" Payment Model for Lower Limb Joint Replacement: Post-acute Care Setting, Costs and Patient Outcomes
评估 CMS 基于前瞻性事件的“捆绑”支付模式对下肢关节置换的效果:急性后护理环境、成本和患者结果
- 批准号:
10217952 - 财政年份:2018
- 资助金额:
$ 69.63万 - 项目类别:
Evaluating the Effects of CMS' Prospective Episode-Based "Bundling" Payment Model for Lower Limb Joint Replacement: Post-acute Care Setting, Costs and Patient Outcomes
评估 CMS 基于前瞻性事件的“捆绑”支付模式对下肢关节置换的效果:急性后护理环境、成本和患者结果
- 批准号:
9982744 - 财政年份:2018
- 资助金额:
$ 69.63万 - 项目类别:
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY TRANSTIBIAL PROSTHESIS
使用创新技术的胫骨假体立即贴合
- 批准号:
9134601 - 财政年份:2015
- 资助金额:
$ 69.63万 - 项目类别:
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY PROSTHETIC SYSTEMS
使用创新技术假肢系统立即贴合
- 批准号:
9339310 - 财政年份:2015
- 资助金额:
$ 69.63万 - 项目类别:
Immediate fit using innovative technology transtibial prosthesis
使用创新技术的小腿假体立即贴合
- 批准号:
8393054 - 财政年份:2011
- 资助金额:
$ 69.63万 - 项目类别:
Immediate fit using innovative technology, transtibial prosthetic system
使用创新技术、经胫骨假肢系统立即贴合
- 批准号:
8122693 - 财政年份:2011
- 资助金额:
$ 69.63万 - 项目类别:
Immediate fit using innovative technology, transtibial prosthesis
采用创新技术的即时贴合,经胫骨假体
- 批准号:
8551681 - 财政年份:2011
- 资助金额:
$ 69.63万 - 项目类别:
Guitars for Vets: Evaluating psychological outcomes of a novel music therapy
退伍军人吉他:评估新型音乐疗法的心理结果
- 批准号:
8002687 - 财政年份:2010
- 资助金额:
$ 69.63万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 69.63万 - 项目类别:
Research Grant